Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 3
Submit an article Journal homepage
46
Views
17
CrossRef citations to date
0
Altmetric
Research Article

The Role of Nucleoside Analogues in the Treatment of Chronic Lymphocytic Leukemia-Lessons Learned from Prospective Randomized Trials

Tadeusz Robak Department of Hematology, Medical University of Łódź, Copernicus Hospital, 93-513 Łódź, ul.Pabianicka 62, Poland
Pages 537-548 | Published online: 01 Jul 2009

  • Rozman, C. and Montserrat, E. (1995) "Chronic lymphocytic leukemia treatment", N. Engl. J. Med. 333, 1052-1057.
  • Kalil, N. and Cheson, B.D. (2000) "Management of chronic lymphocytic leukaemia", Drugs Aging 16, 9-27.
  • Dighiero, G., Maloum, K., Dcsablens, B., Cazin, B., Navarro, M., Leblay, R., Leporrier, M., Jaubert, J., Lepeu, G., Dreyfus, B., Binet, J.L. and Travade, P. (1998) "Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia", N. Engl. J. Med. 338, 1506-1514.
  • Catovsky, D. and Murphy, R.L. (1995) "Key issue in the treatment of chronic lymphocytic leukaemia (CLL)", Eur. J. Cancer 311, 2146-2154.
  • Dighiero, G. and Binet, J.L. (2000) "When and how to treat chronic lymphocytic leukemia", N. Engl. J. Med. 343, 1799-1801.
  • French Co-operative Group on CLL, Binet, J.L. (1993) "Treatment of chronic lymphocytic leukaemia", Baillieres Clin. Haematol. 6, 867-878.
  • Jaksic, B. and Brugiatelli, M. (1988) "High dose continuous chlorambucil vs. intermittent chlorambucil plus prednisone for treatment of B-CLL IGCI CLL-01 trial", Nouv. Rev. Fr. Hematol. 30, 437-442.
  • Sawitsky, A., Rai, K.R., Glidewell, O. and Silver, R.T. (1977) "Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia", Blood 50, 1049-1059.
  • Jaksic, B., Brugiatelli, M., Krc, I., Losonczi, H., Holowiecki, J., Planinc-Peraica, A., Kusec, R., Morabito, F., Iacopino, P. and Lutz, D. (1997) "High dose chlorambucil versus Binet modified cyclophosphamide, doxorubicin, vincristine and prednisone regimen in the treatment multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna", Cancer 79, 2107-2114.
  • Montserrat, E., Alcala, A., Parody, R., Domingo, A., Garcia-Conole, J., Bueno, J., Feren, C., Sanz, P., Giralt, M. and Rubio, D. (1985) "Treatment of chronic lymphocytic leukemia in advanced stage: a randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine and prednisone", Cancer 56, 2369-2375.
  • French Cooperative Group on Chronic Lymphocytic Leukemia (1990) "A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia", Blood 75, 1422-1425.
  • Raphael, B., Andersen, J.W., Silber, R., Oken, M., Moore, D., Bennett, J., Bonnet, H., Hahn, R., Knospe, W.H., Muzza, J. and Glick, J. (1991) "Comparison of chlroambucil and prednisone versus cyclophosphamide, vincristine and prednisone as initial treatment for chronic lymphocytic leukemia: Long-term follow up of an Eastern Cooperative Oncology Group randomized clinial trial", J. Clin. Oncol. 9: 770-776.
  • Kimby, E. and Mellstedt, H. (1991) "Chlorambucil/prednisone versus CHOP in symptomatic chronic lymphocytic leukemia of B-cell type: a randomized trial", Leuk. Lymphoma 5(Suppl.), 93-96.
  • Hansen, M.M., Andersen, E., Birgeus, H., Christensen, B.E., Christensen, T.G. and Gisler, C. (1998) "CHOP versus prednisone+chlroambucil in chronic lymphocytic leukemia: prelimianry results of a randomized multicenter study", Nouv. Rev. Fr. Hematol. 30, 433-436.
  • CLL Trialists Collaborative Group (1999) "Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials", J. Natl Cancer Inst. 91, 861-868.
  • Tallmann, M.S. and Hakimian, D. (1995) "Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders", Blood 86, 2463-2474.
  • Adkins, J.C., Peters, D.H. and Markham, A. (1997). "Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies", Drugs 53; 1005-1037.
  • Robak, T. (2001) "Cladribine in the treatment of chronic lymphocytic leukemia", Leuk. Lymphoma 40, 551-564.
  • The French Cooperative Group on CLL, Johnson, S., Smith, A.G., Loffler, H., Osby, E., Juliusson, G., Emmerich, B., Wyld, P.J. and Hiddemann, W. (1996) "Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin and prednisone (CAP) for treatment of avdanced-stage chronic lymphocytic leukemia. The French Cooperative Group on CLL", Lancet 347, 1432-1438.
  • Rai, K.R., Peterson, B.L., Appelbaum, F.R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G.A., Larson, R.A., Cheson, B.D. and Schiffer, C.A. (2000) "Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia", N. Engl. J. Med. 343, 1750-1757.
  • Spriano, M., Chiurazzi, F., Liso, V., Mazza, P., Molica, S. and Gobbi, M. (2000) "Multicentre prospective randomized trial of fludarabine versus chlroambucil and prednisone in previously untreated patients with active B-CLL: final report", Hematol. Cell Ther. 42, 93, abstract P 086.
  • French Cooperative Group on CLL, Leporrier, M., Chevret, S., Cazin, B., Boudjerra, N., Maloum, K., Feugier, P., Desablens, B., Lepretre, S., Rapp, M.J., Jaubert, J.J., Abgrall, P., Divine, M., Brion, A., Salles, B., Dreyfus, B., Travade, Ph., Rain, J.D., Sebban, C., Soussain, C., Philippe, G., Martin C., Eghbali, H., Bouabdallah, R., Navarro, R., Maisonneuve, I., Le Prise, P.Y., Yacoub-Aga, I., Tertian, G., Rodon, X., Blanc, M., Lepeu, C., Allard, C., Christian, X., Maigre, M., Dighiero, G. and Binet, J.L. (1999) "Randomized clinical trial comparing two anthracyclin-containing regimens (CHOP and CAP) and fludarabine (FDR) in advanced chronic lymphocytic leukemia (CLL)", Blood 94(Suppl. 1), 603a, abstract 2682.
  • Robak, T., Blonski, J.Z., Kasznicki, M., Blasinska-Morawiec, M., Krykowski, E., Dmoszynska, A., Mrugala-Spiewak, H., Skotnicki, A.B., Nowak, W., Konopka, L., Ceglarek, B., Maj, S., Dwilewicz-Trojaczek, J., Hellmann, A., Urasinski, I., Zdziarska, B., Kotlarek-Haus, S., Potoczek, S. and Grieb, P. (2000) "Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial", Blood 96, 2723-2729.
  • Jaksic, B., Brugiatelli, M., Suciu, S., Baumelou, E., Wijermans, P.W., Delmer, A., Roozendaal, K.J., Teixeira, A., Jelm, U., Feremans, W., Belhabri, A., Egyed, M., Venditti, A., Indrak, K., Cevreska, L., Rodts, P., Solbu, G. and Willemze, R. (2000) "Fludarabine versus high-dose continuous chlorambucil in untreated patients with B-CLL: results of CLL1 EORTC randomized trial", Hematol. Cell Ther. 42, 97, abstract P 096.
  • Carrera, C.J., Saven, A. and Piro, L.D. (1994) "Purine metabolism of lymphocytes. Targets for chemotherapy drug development", Hematol. Oncol. Clin. N. Am. 8, 357-381.
  • Beutler, E. (1992) "Cladribine (2-chlorodeoxyadenosine)", Lancet 340, 952-956.
  • Dillman, R.O. (1994) "A new chemotherapeutic agent: deoxycoformycin (pentostatin)", Semin. Hematol. 31, 16-27.
  • Keating, M.J., O'Brien, S., Lerner, S., Koller, C., Beran, M., Robertson, L.E., Freireich, E.J., Estey, E. and Kantarjian, H. (1998) "Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy", Blood 92, 1165-1171.
  • Robak, T., Blonski, J.Z., Kasznicki, M., Konopka, L., Ceglrake, B., Dmoszynska, A., Soroka-Wojtaszko, M., Skotnicki, A.B., Nowak, W., Dwilewicz-Trojaczek, I., Tomaszewska, A., Hellmann, A., Lewandowski, K., Kuliczkowski, K., Potoczek, S., Zdziarska, B., Hansz, J., Kroll, R., Komarnicki, M., Holowiecki, J. and Grieb, P. (2000) "Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukemia--an updated results of the multicenter study of 378 patients", Br. J. Haematol. 108, 357-368.
  • Leblond, V., Ben-Othman, T., Deconinc, E., Taksin, A.L., Harousseau, J.L., Delgado, M.A., Delmer, A., Maloisel, F., Mariette, X., Morel, P., Clauvel, J.P., Duboisset, P., Entazam, S., Herming, O., Merlet, M., Yakoub-Agha, I., Guibon, O., Caspard, H. and Fort, N. (1998) "Activity of fludarabine in previously treated Waldenstrom's macroglobulinemie: a report of 71 cases. Groupe Cooperatif Macroglobulinemie", J. Clin. Oncol. 16, 2060-2064.
  • Hellmann, A., Lewandowski, K., Zaucha, J.M., Bieniaszewska, M., Halaburda, K. and Robak, T. (1999) "Effect of 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenstrom's macroglobulinemia", Eur. J. Haematol. 63, 35-41.
  • Kong, L.R., Sannelson E., Rosen, Roenipk, H.H., Tallman, M.S., Rademaker, A.W. and Kuzel, T.M. (1997) "2-chlorodeoxyadenosine in cutaneous T-cell lymphoproliferative disorders", Leuk. Lymphoma 26, 89-97.
  • Kurzrock, R., Pilat, S. and Duvic, M. (1999) "Pentostatin therapy of T-cell lymphomas with cutaneous manifestations", J. Clin. Oncol. 17, 3117-3121.
  • Grever, M., Kopecky, K., Foucar, M.K., Head, D., Bennett, J.M., Hutchinson, R.C., Corbett, W.E.V., Cassileth, P.A., Habermann, T., Golomb, H., Rai, K., Eisenhauer, E., Appelbaum, F. and Cheson, B.D. (1995) "Randomized comparison of pentostatin versus Interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study", J. Clin. Oncol. 13, 974-982.
  • Saven, A., Burian, C., Koziol, J.A. and Piro, L.D. (1998) "Long-term follow-up of patients with hairy cell leukemia after cladribine treatment", Blood 92, 1918-1926.
  • Robak, T., Blasinska-Morawiec, M., Blonski, J., Hellmann, A., Halaburda, K., Konopka, L., Kotlarek-Haus, S., Potoczek, S., Kansz, J., Dmoszynska, A., Urasinski, I., Zdziarska, B., Dwilewicz-Trojaczek, J., Holowiecki, J. and Skotnicki, A. (1999) "2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland", Eur. J. Haematol. 62, 49-56.
  • Cheson, B.D., Sorensen, J.M., Vena, D.A., Montello, M.J., Barrett, J.A., Darnasio, E., Tallmann, M., Annino, L., Connor, S.J., Coiffier, B. and Lauria, F. (1998) "Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: A report of 979 patients", J. Clin. Oncol. 16, 3007-3015.
  • Kantarjian, H.M., Schachner, J. and Keating, M.J. (1991) "Fludarabine therapy in hairy cell leukemia", Cancer 67, 1291-1293.
  • Bergmann, L. (1997) "Present status of purine analogs in the therapy of chronic lymphocytic leukemias", Leukemia 11(Suppl. 2), S29-S34.
  • Cheson, B.D. (1998) "Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation", Semin. Hematol. 35(Suppl. 3), 14-21.
  • Juliusson, G., Christiansen, I., Hansen, M.M., Johnson, S., Kimby, E., Elmhorn-Rosenberg, A. and Liliemark, J. (1996) "Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia", J. Clin. Oncol. 14, 2160-2166.
  • Delannoy, A., Martiat, P., Gala, J.J., Deneys, V., Ferrant, A., Bosly, A., Schieff, J.M. and Michaux, J.L. (1995) "2-Chlorodeoxyadenosine (CDA) for patients with previously untreated chronic lymphocytic leukemia (CLL)", Leukemia 9, 1130-1135.
  • Saven, A., Lemon, R.H., Kosty, M., Beutler, E. and Piro, L.D. (1995) "2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia", J. Clin. Oncol. 13, 570-574.
  • Robak, T., Blasinska-Morawiec, M., Blonski, J.Z., Krykowski, E., Komarnicki, M., Trepinska, E., Kazmierczuk, M., Hansz, J., Dmoszynska, A., Rolinski, J., Konopka, L., Skotnicki, A.B., Nowak, W.S., Kotlarek-Haus, S., Zdziarska, B. and Urasinski, I. (1987) "The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukemia', Eur. J. Cancer 33, 2347-2351.
  • Tondini, C., Balsarotti, M., Rampinelli, I., Valagussa, P., Luoni, M., De Paoli, A., Santoro, A. and Bonadonna, G. (2000) "Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma, a phase II randomized study", Ann. Oncol. 11, 231-233.
  • Koski, T., Vilpo, L. and Vilpo, J. (1999) "Chemosensitivity in vitro to 2-chlorodeoxyadenosine and 9-beta D-arabinofuranosyl-2-fluoroadenine in previously unexposed cases of chronic lymphocytic leukemia", Leuk. Res. 23, 277-279.
  • Cheson, B.D., Bennet, J.M., Rai, K.R., Grever, M.R., Kay, N.E., Schiffer, C.A., Oken, M.M., Keating, M.J., Boldt, D.H., Kempin, S.J. and Foon, K.A. (1988) "Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendation of the National Cancer Institute Sponsored Working Group", Am. J. Haemtol. 29, 152-163.
  • Keating, M.J., O'Brien, S., Kantarjian, H., Plunkett, W., Estey, E., Koller, C., Beran, M. and Freireich, E.J. (1993) "Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent", Blood 81, 2878-2884.
  • O'Brien, S., Kantarjian, H., Beran, M., Smith, T., Koller, C., Estey, E., Robertson, L.E., Lerner, S. and Keating, M. (1993) "Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis--derived prognostic model for response to treatment", Blood 82, 1695- 1700.
  • Piro, L.D., Carrera, C.J., Beutler, E. and Carson, D.A. (1988) "2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia", Blood 72, 1069-1073.
  • Robak, T., Blonski, J.Z. and Kasznicki, M. (2001) "Does intensive treatment with high dose chlroambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?", Leuk. Lymphoma 41, 545-557.
  • Bergmann, L., Fenchel, K., Jahn, B., Mitrou, P.S. and Hoelzer, D. (1993) "Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia", Ann. Oncol. 4, 371-375.
  • Wijermans, P.W., Gerrits, W.B. and Haak, H.L. (1993) "Severe immunodeficiency in patients treated with fludarabine monophosphate", Eur. J. Haematol. 50, 292-296.
  • Seymour, J.F., Kurzrock, R., Freireich, E.J. and Estey, E.H. (1994) "2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia", Blood 83, 2906-2911.
  • Anaissie, E.J., Kontoyiannis, D.P. O'Brien, S., Kantarjian, H., Robertson, L., Lerner, S. and Keating, M.J. (1998) "Infections in patients with chronic lymphocytic leukemia treated with fludarabine", Ann. Intern. Med. 129, 559-566.
  • Cheson, B.D. (1995) "Infections and immunosuppressive complications of purine analog therapy", J. Clin. Oncol. 13, 2431-2448.
  • Van den Neste, E., Delannoy, A., Vandercam, B., Bosly, A., Ferrant, A., Mineur, P., Montfort, L., Martiat, P., Straetmans, N., Filleul, B. and Michaux, J.L. (1996) "Infections complications after 2-chlorodeoxyadenosine therapy", Eur. J. Haematol. 56, 235-240.
  • Di Raimondo, F., Guistolisi, R., Cacsola, E., Kantarjian, H., Robertson, L.B. and Keating, M. (1993) "Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine", Leuk. Lymphoma 11, 63-68.
  • Myint, H., Copplestone, J.A., Orchard, J., Craig, V., Curtis, D., Prentice, A.G., Hamon, M.D., Oscier, D.G. and Hamblin, T.J. (1995) "Fludarabine related autoimmune haemolytic anemia in patients with chronic lymphocytic leukaemia", Br. J. Haematol. 91; 341-344.
  • Robak, T., Blasinska-Morawiec, M., Krykowski, E., Hellmann, A. and Konopka, L. (1997) "Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukemia treated with 2-chlorodeoxyadenosine (cladribine)", Eur. J. Haematol. 58, 109-113.
  • Chasty, R.C., Myint, H., Oscier, D.G., Orchard, J.A., Bussutil, D.P., Hamon, M.D., Prentice, A.G. and Copplestone, J.A. (1998) "Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA)", Leuk. Lymphoma 29, 391-398.
  • Fleischman, R.A. and Croy, D. (1995) "Acute onset of severe autoimmune hemolytic anemia after treatment with 2-chlorodeoxyadenosine for chronic lymphocytic leukemia", Am. J. Hematol. 48, 293.
  • Manro, F.R., Foa, R., Cerretti, R., Giannarelli, D., Coluzzi, S., Mandelli, F. and Girelli, G. (2000) "Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic and prognostic features", Blood 95, 2786-2792.
  • Chikkappa, G., Zarrabi, M.H. and Tsan, M.F. (1986) "Pure red cell aplasia in patients with chronic lymphocytic leukemia", Medicine-Baltimore 65, 339-351.
  • Leporrier, M., Reman, O. and Troussard, X. (1993) "Pure red-cell aplasia with fludarabine for chronic lymphocytic leukemia", Lancer 342, 555.
  • Robak, T., Kasznicki, M., BloU+144ski, J.Z., Dmoszynska, A. and Skotnicki, A.B. (2001) "Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine", Br. J. Haematol. 112, 1083-1085.
  • Kroft, S.H., Tallman, M.S., Shaw, J.M., Thangavelu, M. and Peterson, L.C. (1997) "Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA) (Letter)", Leukemia 11, 170.
  • Orchard, J.A., Bolam, S. and Oscier, D.G. (1998) "Association of myelodysplastic changes with purine analogues", Br. J. Haematol. 100, 677-679.
  • Van Den Neste, E., Louviaux, I., Michaux, J.L., Delannoy, A., Michaux, L., Hagemeijer, A., Scheiff, J.M., Bosly, A., Straetmans, N. and Ferrant, A. (1999) "Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2'-deoxyadenosine", Br. J. Haematol. 105, 268-270.
  • Meloni, G., Proia, A., Guerrisi, V., Cordone, I., De Cuia, R., Fenu, S., Mauro, F.R., Pescarmona, E., Reato, G. and Mandelli, F. (2000) "Acute myleoid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation", Ann. Oncol. 11, 1493-1495.
  • Cheson, B.D., Vena, D.A., Barrett, J. and Freidlin, B. (1999) "Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias", J. Clin. Oncol. 17, 2454-2460.
  • Giles, F.J., O'Brien, S.M. and Keating, M.J. (1998) "Chronic lymphocytic leukemia in Richter's transformation", Semin. Oncol. 25, 117-125.
  • Robertson, L.E., Pugh, W., O'Brien, S., Kantarjian, H., Hirsch-Ginsberg, C., Cork, A., Mc Laughlin, P., Cabanillas, F. and Keating, M.J. (1993) "Richter's syndrome: a report on 39 patients", J. Clin. Oncol. 11, 1985-1989.
  • Van Den Neste, E., Dellanoy, A., Feemans, W., Ferrant, A. and Michaux, L. (2001) "Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment", Leuk. Lymphoma 40, 541-550.
  • Pocock, C., Matutes, E., Wotherspoon, A., Cunningham, D. and Catovsky, D. (1998) "Fludarabine therapy may precipitate large cell transformation in chronic lymphocytic leukaemia but not in follicular lymphoma", Blood 92(Suppl. 1), 429a, abstract No. 1774.
  • Robak, T., Kasznicki, M., Bartkowiak, J., Kordek, R., Wawrzyniak, E. and Blonski, J.Z. (2001) "Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur", Leuk. Lymphoma, 42, 789-796.
  • Robak, T., Urbanska-Rys, H., Strzelecka, B., Krykowski, E., Bartkowiak, J., Blonski, J.Z., Kordek, R. and Warzocha, K. (2001), "Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA). An unusual variant of Richter's syndrome", Eur. J. Haematol. (in press).
  • Zietz, C., Bogner, J.R., Goebel, F.D. and Lohrs, U. (1999) "An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS", N. Engl. J. Med. 340, 1923-1924.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.